Goed stuk van @ellaweggen.bsky.social waarin ze uitlegt waarom voorwaarden aan publieks financiering van medicijn onderzoek toegang tot medicijnen kan verbeteren: www.nrc.nl/nieuws/2026/...

Opinie | Wetenschappelijk succes meet je óók af aan de vraag wie ervan profiteert

Medicijnontwikkeling: Medicijnonderzoek wordt vaak betaald met publiek geld. Nederland en Europa hebben nu de kans om te bepalen dat gesubsidieerde medicijnen te allen tijde betaalbaar worden voor wie...

nrc.nl

Here is the solution to the stalled WHO PABS negotiations, needed to clear the last roadblock to ratification and entering into force of the Pandemic Agreement. @jamielove.bsky.social www.keionline.org/41368

De-linking equitable sharing of Pandemic production obligations from access to PABS materials and data - Knowledge Ecology International

I’m in Geneva this week and next, and Brussels on Monday. The WIPO General Assembly meets this week. A two week WHO negotiation on an Annex to the Pandemic Agreement on Pathogen Access and Benefit Sha...

keionline.org

This morning at the opening session of the 6th session of the WHO PABS negotiations we supported this proposal made by @keiwashdc.bsky.social #pandemicagreement

Thiru Balasubramaniam@thirugeneva.bsky.social · last mo.

On the Occasion of the #G7 Summit An Open Letter to the Leaders of the G7, the G20, BRICS & All Nations On finalizing the Pathogen Access & Benefit-Sharing annex of the WHO Pandemic Agreement ⬇️ @lulaoficialbluesky.bsky.social President of #Brazil Dr Tedros Adhanom Ghebreyesus DG of @who.int

FT Exclusive: Four months after its establishment, the organisation’s financial fund set up by the World Bank has received no money from donors, according to four people familiar with the matter. ft.trib.al/LQLpKfw

This is an interesting new @medicinespatentpool.org licence. Generic manufacturers, anywhere in the world, interested in producing baloxavir marboxil should contact the MPP through its expression of interest portal: medicinespatentpool.org/partners/how...

How to Give or Get a Licence - MPP

MPP licence agreements’ aim is to make safe, effective and affordable essential medicines available in low- and middle-income countries.

medicinespatentpool.org

Medicines Patent Pool@medicinespatentpool.org · 3mo ago

Today at #WHA79, MPP and Roche celebrated the signing of a public health-oriented voluntary licence agreement for baloxavir marboxil, an #influenza antiviral treatment recommended by @who.int. Read the announcement: bit.ly/4wwZsW1 @unitaid.bsky.social @drduneton.bsky.social

Our blog on the state of play in the @who.int PABS negotiations. medicineslawandpolicy.org/2026/05/worl...

📢 Maak #geengeheim van mijn medicijn. @ellenthoen.bsky.social is expert patentrecht en directeur van @medslawpolicy.bsky.social. Zij ondertekende de open brief aan de regering en Tweede Kamer voor meer transparantie in de farma-sector. ✍ Lees en onderteken de brief op www.wemos.org/geengeheim.

When the @who.int Executive Board discusses agenda item 14 on the draft updated global action plan on antimicrobial resistance (perhaps tomorrow), VMAT may crop up as a point of contention. @who.int #EB158

Just out: our overview of over two decades of the use of TRIPS flexibilities to access medicines in BMJ Global Health gh.bmj.com/content/11/1...

TRIPS flexibilities help change policy and practice to increase access to medicines: evidence from 2001 to 2024

Introduction Millions of people lack access to safe and effective pharmaceuticals because they are unaffordable or unavailable, particularly in ‘developing’ and ‘least-developed’ countries (DCs, LDCs)...

gh.bmj.com

Met dank aan @wemos.org om mij hierbij te betrekken. Transparantie is de basis van een democratische samenleving en het vertrouwen in de instituties en bedrijven die er actief zijn. Dat geldt ook voor de farmaceutische industrie.

Wemos@wemos.org · 6mo ago

💊💰🔎 De farma-industrie is uitzonderlijk en vraagt daarom om uitzonderlijke regulering. Transparantie is nodig voor eerlijke medicijnprijzen. Aldus @ellaweggen.bsky.social van Wemos, @ellenthoen.bsky.social en @katperehudoff.bsky.social in @volkskrant.nl. Lees: www.volkskrant.nl/columns-opin...

Meanwhile: US has now left the @who.int “The U.S. flag had been removed from outside the WHO headquarters in Geneva on Thursday, according to witnesses.” www.reuters.com/business/hea...

US withdraws from the World Health Organization

The United States officially left the World Health Organization on Thursday after a year of warnings that doing so would hurt public health in the U.S. and globally, saying its decision reflected fail...

reuters.com

New Oxfam Inequality report just dropped: Billionaire wealth has grown by 80% since 2020. The world’s 12 richest billionaires have more wealth than the poorest half of humanity. Elon Musk is the first ever person to have over half a trillion dollars wealth.

US pharma threaten to withhold products from Europe over prices giftarticle.ft.com/giftarticle/...

US drugmakers threaten to withhold products from Europe over prices

Pharmaceutical companies seek to make up any lost revenue after striking deals with Donald Trump to lower costs in US

giftarticle.ft.com

Nice tribute to David Mitchell, a US drug pricing advocate who recently passed away. @statnews.com www.statnews.com/2026/01/05/d...

With political savvy and outrage over drug prices, advocate David Mitchell was ahead of his time

David Mitchell, who helped launch Patients for Affordable Drugs to raise awareness of high drug prices and seek to bring them down, died at age 75.

statnews.com

Apparently non-State actors in official relations and relevant stakeholders are not welcome (physically) at the resumed session of #IGWG4 in January 2026: "Please also note that Relevant Stakeholders are invited to participate in the meeting virtually."

Here is my end of the year blog with a highly biased listing of noteworthy medicines law and policy events of 2025: medicineslawandpolicy.org/2025/12/wrap...

I am looking forward to being part of the launch event of the Centre on Knowledge Governance tonight at the @gvagrad.bsky.social docs.google.com/document/d/1...

Draft Program - Centre Launch 3 Dec

Centre on Knowledge GovernanceLaunch Event and Reception Wednesday 3 December 2025, 6.00pm - 9.30pm, including receptionAuditorium A-2, Petal 2, Graduate Institute, Chem. Eugène-Rigot 2, 1202 Genèv...

docs.google.com

“Transitioning to self-reliance sounds good but what is happening today is not a transition. It is a shock to the system of which the most vulnerable will carry the brunt”, says @ellenthoen.bsky.social in a new @thelancet.com here:

Global health aid cuts: WHO urges urgent action to protect vulnerable populations

With drastic reductions in health aid threatening essential services and millions of lives, WHO issues new guidance for countries to safeguard health budgets, limit out-of-pocket payments, and mobilis...

thelancet.com

France is killing it - net price transparency now, ammendment tabled and adopted ! @healthlawadamh.bsky.social @mattherder.bsky.social

Jaime Manzano@jaimemanzano.bsky.social · 9mo ago

Important development in France for those following #pharma #transparency. Socialist MPs have proposed an amendment to the 2026 Social Security Financing Bill that could redefine transparency in how medicines are financed and priced. /1🧵 www.assemblee-nationale.fr/dyn/17/amend...

Fully support this morning’s statement by @theindpanel.bsky.social at the #PABS talks at the WHO. It relates to the news broken by @healthpolicywatch.bsky.social that the US is seeking access to pathogen information in exchange for health funding. healthpolicy-watch.news/exclusive-us...

EXCLUSIVE: US Ties Global Health Aid To Data Sharing On Pathogens – Undermining WHO Talks - Health Policy Watch

The United States (US) aims to compel countries that receive its aid to fight HIV, tuberculosis and malaria to share all information about “pathogens with

healthpolicy-watch.news

The Independent Panel for Pandemic Preparedness and Response @theindpanel.bsky.social · 9mo ago

This am @theindpanel.bsky.social made a statement to #IGWG3 concerning bilateral health deals: "...these bilateral agreements will undermine the multilateral system. They will bypass the WHO, and the foundations of solidarity and equity we have been trying to build here." tinyurl.com/mr4dyr54

on.ft.com/493t0RL War is pushing us to a drug resistance tipping point by @gardp.bsky.social

War is pushing us to a drug resistance tipping point

Failure to prevent the rise and spread of infections in conflict zones imperils health security everywhere

on.ft.com

Last chance to register for the Amsterdam Medicines Justice Conference. registration closes tomorrow: www.aanmelder.nl/medicinesjus...

Medicines justice - Registration

aanmelder.nl

Meanwhile on the dark side:

The @wto.org just published its 2025 World Trade Report on trade and AI to the benefit for all: www.wto.org/english/res_...

Because “contraception is not life-saving” www.nytimes.com/2025/09/11/h...

$10 Million in Contraceptives Have Been Destroyed on Orders From Trump Officials

nytimes.com

Next week, at the @who.int the second meeting of the Intergovernmental Working Group (IGWG) tasked with negotiating the PABS Instrument will take place. We just published this brief on the subject: medicineslawandpolicy.org/2025/09/who-...

The WHO Foundation should clean up its act. And so should member states by supporting the @who.int with core financing. www.theguardian.com/world/2025/s...

Alarm as WHO accepts increasing amount of dark money from corporate donors

Experts say millions in corporate funding and concealment of donors’ identities raises key conflict-of-interest concerns

theguardian.com

GLP-1 drugs have been on the Medicines Patent Pool priority list for a while. Time for the companies to come forward now @who.int labeled them essential @thirugeneva.bsky.social @medicinespatentpool.org

Peter Singer@petersinger.bsky.social · 11mo ago

On Sept 5th, @who.int listed GLP-1 drugs on its Essential Medicines List. This listing covers about 75% of the 2.1 m lives saved per year in the lower estimate of the model David Brook and I developed. See the details on the screenshot below from our preprint: www.medrxiv.org/content/10.1... 1/n